Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, is pleased to announce that its Argus II Retinal Prosthesis System (Argus II), has been recognised by Popular Science magazine as
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:14Second Sight Medical Products? Argus II named Invention of the Year by Popular Science magazine
Doctors have been urged to change how they prescribe medicines to stop
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:18Doctors urged to cut medicine prescription waste
Being able to provide high-quality health care is a primary driver of job satisfaction among physicians, and obstacles to quality patient care are a source of stress for doctors, according to a new RAND Corporation study.
While physicians note some advantages of electronic health records, physicians complain that the systems in use today are cumbersome to operate and are an important contributor to their dissatisfaction, the study found.
The findings suggest that the factors contributing to physician dissatisfaction could serve as early warnings of deeper quality problems developing in the health care system.
‘Many things affect physician professional satisfaction, but a common theme is that physicians describe feeling stressed and unhappy when they see barriers preventing them from providing quality care,’ said Dr. Mark Friedberg, the study’s lead author and a natural scientist at RAND, a non-profit research organisation. ‘If their perceptions about quality are correct, then solving these problems will be good for both patients and physicians.’
The findings are from a project, sponsored by the American Medical Association (AMA), designed to identify the factors that influence physicians’ professional satisfaction. The issue is of increasing importance as health reform and other forces in the U.S. health care system alter contemporary delivery and payment models.
‘Overcoming modern medicine’s greatest obstacles to first-rate medical care can simultaneously enhance the quality of care and improve professional satisfaction among physicians,’ said AMA President Dr. Ardis Dee Hoven. ‘The AMA is committed to leading a national dialog regarding the major factors driving many physicians to feel increasingly disconnected from what really matters
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:22Quality of patient care drives physician satisfaction
Researchers from the University of Dundee have developed a new strategy for prescribing antibiotics that could reduce patient harm and help combat the rise in antibiotic resistance.
A new study found that a new prescribing protocol could significant reduce potential misuse of antibiotics.
The research followed over 500 patients with lower respiratory tract infections during the course of one year. The new prescribing protocol included automatic stop dates, with time limits on prescriptions depending on the severity of an infection, coupled with support from pharmacists to ensure that antibiotics were issued with stop dates that were clearly visible for patients.
During the first half of the 12-month trial, researchers monitored patients’ current duration of antibiotic use. In the second half, patients receiving antibiotics followed the new prescribing strategy. During both phases of this study, researchers monitored antibiotic side-effects, including new symptoms occurring during the period of antibiotic exposure that were potentially caused by the antibiotics. They also monitored patients’ length of stay in hospital and death rates.
The study found that when the new protocol was followed, there was a near 20 per cent reduction in antibiotic use and an associated 40 per cent reduction in antibiotic-related side-effects.
Dr Matthew Lloyd, lead author from the University’s School of Medicine, said, ‘The threat from growing resistance to antibiotics is increasing, which is in part attributable to inappropriately lengthy courses of antibiotics.
‘Our study aimed to implement a simple system for preventing patients taking antibiotics for longer than they should. The results were promising and found that through prescribing automatic stop dates and working with our multidisciplinary colleagues, we can help prevent this problem and reduce patient harm.’
University of Dundee
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:25New strategy could reduce inappropriate use of antibiotics
A patient in a seemingly vegetative state, unable to move or speak, showed signs of attentive awareness that had not been detected before, a new study reveals. This patient was able to focus on words signalled by the experimenters as auditory targets as successfully as healthy individuals. If this ability can be developed consistently in certain patients who are vegetative, it could open the door to specialized devices in the future and enable them to interact with the outside world. For the study, the researchers used electroencephalography (EEG), which non-invasively measures the electrical activity over the scalp, to test 21 patients diagnosed as vegetative or minimally conscious, and eight healthy volunteers. Participants heard a series of different words – one word a second over 90 seconds at a time – while asked to alternatingly attend to either the word
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:08Patient in ?vegetative state? not just aware, but paying attention
Rice University nanotechnology researchers have unveiled a solar-powered sterilization system that could be a boon for more than 2.5 billion people who lack adequate sanitation. The
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:11Off-grid sterilization with ‘solar steam’
Use of a minimally invasive endoscopic procedure to remove superficial, early stage oesophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida. The research examined national outcomes from endoscopic treatment compared to esophagectomy, surgical removal of the oesophagus.
It found that endoscopic therapy offered long-term survival rates similar to those for oesophagectomy, says lead author, Michael B. Wallace, M.D., a gastroenterologist at Mayo Clinic in Florida.
‘Endoscopic resection in the oesophagus is similar to how we remove polyps in the colon, although it is much more technically complex. Oesophagectomy is a major surgical procedure that cuts out the entire oesophagus, and pulls the stomach into the neck to create a new food tube,’ Dr. Wallace says.
‘Our study on national outcomes, as well as our own experience with the procedure at Mayo Clinic in Florida, suggests that both offer the similar chances for cure and long-term survival,’ he says. ‘Patients now have the option to preserve their oesophagus when only early stage cancer is present.’
The research looked at national outcomes from the two procedures in patients with oesophageal adenocarcinoma, the most common type of oesophageal cancer in the United States. The research team examined data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database.
They identified 1,619 patients with superficial, early stage oesophageal adenocarcinoma who had endoscopic therapy (19 percent) or surgery (81 percent) from 1998 through 2009. Many of these patients were treated for cancers that arose from Barrett’s oesophagus, a condition in which the cells in the lower part of the oesophagus morph into a pre-cancerous state.
The researchers collected survival data through the end of 2009, and found that endoscopy therapy increased progressively
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:15Less-invasive option as effective as oesophagus removal in early oesophageal cancer
Improving vaccination rates against the human papillomavirus (HPV) in boys aged 11 to 21 is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty of Social Work. HPV has been linked to anal, penile and certain types of throat cancers in men. Since the virus is also responsible for various cancers in women, vaccinating boys will play a crucial role in reducing cancer rates across the sexes.
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:18Vaccinating boys plays key role in HPV prevention
Andrea Morelli, M.D., of the University of Rome, Italy, and colleagues conducted a study to investigate the effect of the short-acting beta-blocker esmolol on the heart rate of patients with severe septic shock and high risk of death.
Septic shock is associated with adverse effects on cardiac function. Beta-blocker therapy controls heart rate and may improve cardiovascular performance, but concerns remain that this therapy may lead to cardiovascular decompensation (inability of the heart to maintain adequate circulation), according to background information in the article.
The randomised phase 2 study was conducted in a university hospital intensive care unit (ICU) between November 2010 and July 2012. It recruited patients in septic shock with a heart rate of 95/min or higher requiring high-dose norepinephrine to maintain an average arterial pressure of 65 mm Hg or higher. The researchers randomly assigned 77 patients to receive a continuous infusion of esmolol to maintain heart rate between 80 beats per minute (BPM) and 94 BPM for the duration of their ICU stay and 77 patients to standard treatment. The primary outcome was a reduction in heart rate below the predefined threshold of 95 BPM and maintain a heart rate between 80 and 94 BPM over a 96-hour period.
The researchers found that the target range for heart rate was achieved in all patients in the esmolol group, which was significantly lower throughout the intervention period than what was achieved in the control group. In addition, the esmolol group had a 28-day mortality rate of 49.4 percent vs. 80.5 percent in the control group. Overall survival was higher in the esmolol group.
There was no clinically relevant differences between groups in other investigated cardiopulmonary variables nor in rescue therapy requirements.
‘Further investigation of the effects of esmolol on clinical outcomes is warranted,’ the authors write.
EurekAlert
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:22Use of beta-blocker helps achieve target heart rate level among patients in septic shock
An electronic decision support tool helped to reduce deaths from pneumonia in four hospital emergency departments in a new study.
Although guidelines for treating pneumonia exist, it is often difficult for these to be fully implemented in an emergency setting. The researchers therefore developed an electronic tool, linked to a patient’s medical record. Unlike a paper guideline, the tool automatically extracts data that predict the severity of pneumonia. The tool then provides recommendations regarding where the patient should be admitted to, which diagnostic tests are best to use and which antibiotics are most appropriate.
Researchers from Intermountain Healthcare and the University of Utah in the USA tested the effectiveness of the tool on pneumonia patients in seven emergency departments. The first group of 2,308 patients were analysed before the electronic tool was used. A later group of 2,450 patients were assessed when four of the seven emergency departments used the electronic tool.
In both groups the researchers looked at hospital admission rates, length of hospital stay, deaths, secondary hospitalisation rates and adherence to guidelines.
The results showed a significant reduction in death rates in the emergency departments where the tool was used. Crude inpatient mortality rate fell from 5.3% to 3.5% and, after adjusting for severity, the relative risk of death was reduced by 25%.
EurekAlert
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:042020-08-26 14:41:25Electronic tool helps reduce deaths from pneumonia in emergency departments
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.